Taking advantage of new models and tools to rethink efficacy and Safety Research
During the 2023 Safety Pharmacology Society (SPS) Conference in Brussels, Dr. Dany Salvail (IPST, QC, Canada) explained how experienced pharmacologists rely on alternate models combined with sophisticated measurement techniques that go well beyond the ICH guidelines to help sponsors truly understand and quantify liabilities associated with their lead compounds early on.
Safety Pharmacology
Safety Pharmacology Safety pharmacology investigates potential undesirable effects of drugs on physiological functions, to predict safety before bringing to market. emka TECHNOLOGIES provides complete solutions to meet your GLP or non-GLP Safety Pharmacology needs. Our solutions allow for efficient data collection and analysis, in-line with ICH requirements, spanning in-vivo and ex-vivo applications. The core battery […]
